跳至主要内容
临床试验/NCT01899248
NCT01899248已完成不适用

The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
corrected QT interval (QTc interval)

研究概览

简要总结

The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective liver transplantation

排除标准

  • age < 18, age > 65
  • patient refusal
  • re-transplantation

研究组 & 干预措施

Sevoflurane

Performing liver transplantation under general anesthesia using sevoflurane

干预措施: Sevoflurane (Drug)

Desflurane

Performing liver transplantation under general anesthesia using desflurane

干预措施: Desflurane (Drug)

结局指标

主要结局

corrected QT interval (QTc interval)

时间窗: up to postoperative day 1 after surgery

up to 10 minutes after tracheal intubation, up to 60 minutes after reperfusion, at 10 minutes after hepatectomy, at 10 minutes after biliary anastomosis, at skin closure, at the arrival on ICU, on postoperative day 1.

次要结局

  • proportion of patients whose QTc interval is more than 450 ms for men and 470 ms for women(up to postoperative day 1 after surgery)
  • proportion of patients who have more than 500 ms of QTc interval(up to postoperative day 1 after surgery)
  • Tp-e interval(up to postoperative day 1 after surgery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验